Cited 4 times since 2019 (0.7 per year) source: EuropePMC Pharmacogenomics, Volume 20, Issue 18, 1 1 2019, Pages 1255-1257 Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment. Del Re M, Addeo A, Passaro A, Petrini I, van Schaik RH, Danesi R